Valore del farmaco, innovazione e criteri di valutazione

Most read articles by the same author(s)

• Giovanni Corrao, Giovanni Alquati, Giovanni Apolone, Andrea Ardizzoni, Giuliano Buzzetti, Giorgio W. Canonica, Pierfranco Conte, Elisa Crovato, Francesco Damele, Carlo La Vecchia, Aldo P. Maggioni, Alberto Mantovani, Michele Marangi, Walter Marrocco, Andrea Messori, Alessandro Padovani, Alessandro Rambaldi, Walter Ricciardi, Francesco Ripa di Meana, Federico Spandonaro, Valeria Tozzi, Giuseppe Mancia, Real-world data: how they can help to improve quality of care , Global and Regional Health Technology Assessment: Vol. 8 No. 1 (2021): January-December 2021
• Claudio Jommi, Giovanni Apolone, Giovanna Scroccaro, Valentina Acciai, Antonio Addis, Andrea Ardizzoni, Renato Bernardini, Alberto Bortolami, Alessia Brigido, Giuliano Buzzetti, Pier Luigi Canonico, Francesca Caprari, Stefano Centanni, Chiara Cernetti, Americo Cicchetti, Giorgio Corsico, Francesco Damele, Filippo De Braud, Sara Manurita, Francesco Saverio Mennini, Irene Olivi, Federica Parretta, Lara Pippo, Stefania Pulimeno, Massimo Riccaboni, Giuseppe Rossi, Cecilia Saleri, Alessandra Sinibaldi, Federico Spandonaro, Cristian Stefenoni, Elena Visentin, Pierluigi Viale, Giuseppina Zapparelli, Patrizia Popoli, Drugs price and reimbursement regulation: comparators, endpoints and role of the cost-effectiveness , Global and Regional Health Technology Assessment: Vol. 9 No. 1 (2022): January-December 2022
• Andrea Messori, Valeria Fadda, Sabrina Trippoli, ‘Therapeutic Alternatives’: Procurement Rules for Drugs with Same Indication but without Equivalence Certification Released According to the Balduzzi Law , Global and Regional Health Technology Assessment: Vol. 2 No. 3 (2015): September-December 2015
• Andrea Messori, Sabrina Trippoli, The Benefit of Oncological Drugs: Commentary on the Article by Ballatori and Colleagues , Global and Regional Health Technology Assessment: Vol. 2 No. 3 (2015): September-December 2015
• Federico Spandonaro, Diana Giannarelli, Barbara Polistena, Some Considerations about the Value Based Pricing in Oncology: An Analysis on Metastatic First Line Medicinal Products , Global and Regional Health Technology Assessment: Vol. 3 No. 1 (2016): January-April 2016
• Maria Lucia Marino, Eva Alessi, Aurora Di Filippo, Barbara Polistena, Francesco Macchia, Federico Spandonaro, Francesco Trotta, Orphan drugs in Italy: availability and time-to-access at regional level , Global and Regional Health Technology Assessment: Vol. 10 No. 1 (2023): January-December 2023